Geode Capital Management
BTCY

Geode Capital Management’s Biotricity, Inc. Common Stock BTCY Stock Holding History

Geode Capital Management’s Portfolio BTCY Stock Details BTCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-72,245
Closed -$65K – 4639
2024
Q2 		$65K Buy
72,245
+8,171
+13% +$9.41K ﹤0.01% 4231
2024
Q1 		$94.8K Hold
64,074
– – ﹤0.01% 4175
2023
Q4 		$75.6K Hold
64,074
– – ﹤0.01% 4259
2023
Q3 		$134K Buy
64,074
+40
+0.1% +$97 ﹤0.01% 4144
2023
Q2 		$241K Hold
64,034
– – ﹤0.01% 3961
2023
Q1 		$179K Hold
64,034
– – ﹤0.01% 4105
2022
Q4 		$173K Sell
64,034
-148
-0.2% -$818 ﹤0.01% 4177
2022
Q3 		$308K Buy
64,182
+222
+0.3% +$1.56K ﹤0.01% 3974
2022
Q2 		$679K Buy
63,960
+727
+1% +$6.34K ﹤0.01% 3592
2022
Q1 		$861K Hold
63,233
– – ﹤0.01% 3682
2021
Q4 		$1.51M Buy
63,233
+57,971
+1,102% +$1.37M ﹤0.01% 3513
2021
Q3 		$93K Buy
+5,262
New +$98.8K ﹤0.01% 4694

Other funds holding BTCY

SFCL
Strengthening Families & Communities LLC Boston, Massachusetts $450M AUM 41.19% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
PWA
Provenance Wealth Advisors Fort Lauderdale, Florida $1.05B AUM 18.67% 1-Year Est. Return
PGAM
Princeton Global Asset Management Princeton, New Jersey $698M AUM 31.09% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return

Geode Capital Management's BTCY Position: Q3 2024 in Review

Geode Capital Management sold out of Biotricity, Inc. Common Stock (BTCY) in Q3 2024, closing a stake of 72,245 shares — an estimated $65K sold.

Geode Capital Management first reported a position in BTCY in Q3 2021 and held it in 12 quarters. The position peaked at $1.51M in Q4 2021. 5 funds tracked by Wall St. Rank hold BTCY as of Q3 2024.

  • Geode Capital Management reported no remaining Biotricity, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Geode Capital Management sold 72,245 Biotricity, Inc. Common Stock shares in Q3 2024, an estimated $65K.
  • Geode Capital Management first reported a position in Biotricity, Inc. Common Stock in Q3 2021 and held it in 12 quarters.
  • Geode Capital Management's Biotricity, Inc. Common Stock position peaked at $1.51M in Q4 2021.
  • 5 funds tracked by Wall St. Rank held Biotricity, Inc. Common Stock as of Q3 2024.

Based on Geode Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.